Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.
Hum Reprod. 2012 Jul;27(7):2030-5. doi: 10.1093/humrep/des131. Epub 2012 May 2.
BACKGROUND Live birth per cycle and live birth per embryo transfer are commonly used outcome measures for IVF treatment. In contrast, the assessment of the reproductive efficiency of human oocytes fertilized in vitro is seldom performed on an egg-to-egg basis. This approach may however gain importance owing to the increasingly widespread use of oocyte cryopreservation, as the technique is becoming more established. The aim of the current study is to quantify the reproductive efficiency of the oocyte according to ovarian ageing and ovarian response. METHODS We performed a retrospective analysis of the outcome of all consecutive patients attending for treatment between 1992 and 2009. The outcome in terms of live birth after fresh and cryopreserved embryo transfer per mature oocyte was calculated for 207 267 oocytes retrieved in 23 354 ovarian stimulation cycles. The oocyte utilization rate (number of live births per mature oocyte) was further analysed in relation to the ovarian response. RESULTS The oocyte utilization rate in women in the age of ≤ 37 years remains constant with a mean of 4.47% live birth per mature oocyte [95% confidence interval (CI): 4.32-4.61]. From the age of 38 years onwards, a significantly lower oocyte utilization rate was noted, declining from 3.80% at the age of 38 years to 0.78% at 43 years (P < 0.001). In this 38-43 years age group, oocyte utilization rate was no longer dependent on ovarian response (P = 0.87). CONCLUSIONS The major strength of the study, which is also its weakness, is the fact that we included a large number of cycles performed over a long period of time. According to our results, the oocyte utilization rate between 23 and 37 years of age depends largely on ovarian response and to a much lesser extent on age. From the age of 38 years onwards, the utilization rate depends largely on age and to a much lesser extent on ovarian response. Considering the increased use of oocyte freezing for fertility preservation, these data are extremely valuable as they provide an estimate of the number of oocytes needed to achieve a live birth.
在体外受精治疗中,活产周期数和活产胚胎移植数通常被用作疗效评估的指标。相比之下,基于卵子的卵母细胞体外受精的生殖效率评估很少基于卵对卵的基础上进行。然而,由于卵母细胞冷冻技术的广泛应用,该技术越来越成熟,因此这种方法可能会变得越来越重要。本研究旨在根据卵巢老化和卵巢反应来量化卵母细胞的生殖效率。
我们对 1992 年至 2009 年期间连续就诊的所有患者的治疗结果进行了回顾性分析。根据新鲜胚胎和冷冻胚胎移植后每枚成熟卵母细胞的活产数,对 23354 个卵巢刺激周期中取出的 207267 枚卵母细胞的结果进行了计算。进一步分析了卵母细胞利用率(每枚成熟卵母细胞的活产数)与卵巢反应的关系。
≤37 岁的女性卵母细胞利用率保持不变,平均每枚成熟卵母细胞活产 4.47%(95%置信区间:4.32-4.61)。38 岁以后,卵母细胞利用率明显下降,从 38 岁时的 3.80%下降到 43 岁时的 0.78%(P<0.001)。在 38-43 岁年龄组中,卵母细胞利用率不再依赖于卵巢反应(P=0.87)。
本研究的主要优势也是其局限性在于,我们纳入了大量在较长时间内进行的周期。根据我们的结果,23-37 岁之间的卵母细胞利用率在很大程度上取决于卵巢反应,而年龄的影响较小。38 岁以后,利用率在很大程度上取决于年龄,而卵巢反应的影响较小。考虑到卵母细胞冷冻技术在生育力保存方面的应用越来越多,这些数据具有极高的价值,因为它们提供了实现活产所需的卵母细胞数量的估计。